UTI's $115 Mil. IPO Proceeds To Pay Down Debt From Acquisitions
This article was originally published in The Gray Sheet
Executive Summary
UTI Corp.'s proposed initial public offering of up to $115 mil. in common stock will help the medical device component manufacturer retire a portion of the nearly $140 mil. in long-term debt resulting from a series of mergers and acquisitions that helped the company take its current form.
You may also be interested in...
UTI/MedSource Combo Targets Large-Scale Medical Device Outsourcing
Privately held UTI Corp. expects its $230 mil. purchase of MedSource Technologies to create a one-stop specialty outsourcing venue for large-cap original equipment manufacturers
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.